Oxford Biomedica plc (LON: OXB)
London
· Delayed Price · Currency is GBP · Price in GBX425.00
-1.50 (-0.35%)
Dec 23, 2024, 4:35 PM BST
Oxford Biomedica Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -142.02 | -157.49 | -39.16 | 19.01 | -6.25 | -16.07 | Upgrade
|
| Depreciation & Amortization | 16.85 | 21.51 | 20.29 | 12.46 | 9.84 | 5.79 | Upgrade
|
| Other Amortization | 8.51 | 7.21 | 6.66 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.38 | -0.82 | -21.33 | - | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 99.29 | 99.29 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.07 | - | 0.05 | 0.17 | 0.83 | 1.88 | Upgrade
|
| Stock-Based Compensation | 1.42 | 3.52 | 6.47 | 3.98 | 3.29 | 2.25 | Upgrade
|
| Other Operating Activities | -21.36 | -19.17 | 9.5 | 2.75 | 7.56 | 4.73 | Upgrade
|
| Change in Accounts Receivable | -8.32 | 28.79 | -17.88 | 6.89 | -25.89 | -4.59 | Upgrade
|
| Change in Inventory | -0.13 | -0.25 | 0.67 | -2.61 | -4.33 | 1.67 | Upgrade
|
| Change in Accounts Payable | -8.68 | -18.13 | 16.96 | -0.66 | 5.42 | 2.87 | Upgrade
|
| Change in Unearned Revenue | -7.53 | 7.03 | 5.16 | -16.53 | 12.62 | -2.1 | Upgrade
|
| Change in Other Net Operating Assets | -0 | 0 | - | - | 0.04 | 0.06 | Upgrade
|
| Operating Cash Flow | -62.3 | -28.52 | -12.62 | 25.46 | 3.12 | -3.51 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 716.91% | - | - | Upgrade
|
| Capital Expenditures | -9.79 | -9.83 | -16.3 | -9.46 | -13.36 | -25.77 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.61 | 8.39 | 60 | - | - | 0 | Upgrade
|
| Cash Acquisitions | 9 | - | -99.21 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | 2.52 | 6.27 | Upgrade
|
| Other Investing Activities | 4.49 | 4.25 | -0.96 | - | 0.03 | 0.1 | Upgrade
|
| Investing Cash Flow | 8.31 | 2.81 | -56.46 | -9.46 | -10.8 | -19.4 | Upgrade
|
| Long-Term Debt Issued | - | - | 64.87 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.12 | -32.54 | -4.52 | -0.29 | -44.42 | Upgrade
|
| Net Debt Issued (Repaid) | -3.59 | -3.12 | 32.32 | -4.52 | -0.29 | -44.42 | Upgrade
|
| Issuance of Common Stock | 17.22 | 0.65 | 80.15 | 51.6 | 41.06 | 55.48 | Upgrade
|
| Other Financing Activities | -9.66 | -10.24 | -13.85 | -0.87 | -2.58 | -4.15 | Upgrade
|
| Financing Cash Flow | 3.97 | -12.7 | 98.62 | 46.21 | 38.19 | 6.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2 | 0.85 | 2.8 | - | - | - | Upgrade
|
| Net Cash Flow | -48.02 | -37.57 | 32.34 | 62.2 | 30.5 | -16 | Upgrade
|
| Free Cash Flow | -72.09 | -38.35 | -28.91 | 15.99 | -10.24 | -29.28 | Upgrade
|
| Free Cash Flow Margin | -74.11% | -42.83% | -20.65% | 11.20% | -11.67% | -45.71% | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.40 | -0.30 | 0.19 | -0.13 | -0.40 | Upgrade
|
| Cash Interest Paid | 9.66 | 10.24 | 7.68 | 0.87 | 0.86 | 2.51 | Upgrade
|
| Cash Income Tax Paid | - | -7.51 | -0.56 | -0.99 | -7.01 | -3.13 | Upgrade
|
| Levered Free Cash Flow | -34.93 | -17.12 | -12.82 | 10.88 | -6.82 | -33.78 | Upgrade
|
| Unlevered Free Cash Flow | -28.69 | -10.45 | -7.98 | 11.42 | -6.27 | -30.35 | Upgrade
|
| Change in Net Working Capital | 4.74 | -20.9 | -4.52 | 9.39 | 3.47 | 4.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.